Sclerosis: all 3,103 studies
Page 21 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.
- Genomic Translation for Amyotrophic Lateral Sclerosis CareCompletedNCT02795897
- Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic InflammationCompletedNCT02794857Phase 2
- Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) SyndromeCompletedNCT02790307Phase 2
- Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis PatientsCompletedNCT02789670
- Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MSCompletedNCT02782858Phase 2
- Motor Imagery Training in Persons With Multiple SclerosisCompletedNCT02781142Not applicable
- Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)CompletedNCT02776072
- Effect of an Internet-based At-home Physical Training Protocol on Quality of Life, Fatigue, Functional Performance, Aerobic Capacity and Muscle Strength in Multiple Sclerosis PatientsCompletedNCT02771652Not applicable
- Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.Status unknownNCT02769767
- Methylprednisolone During the Switch Between Natalizumab and FingolimodStatus unknownNCT02769689Phase 4
- Telerehabilitation Upper Extremity for Neurological DisordersCompletedNCT02764372Phase 1
- Motivation of Patients Diagnosed With Multiple Sclerosis to Become Citizen ResearchersStatus unknownNCT02760082
- A Study to Evaluate the Performance of a Diagnostic Test in ALSStatus unknownNCT02759913
- Pilot Trial of Backwards Walking in Persons With Multiple SclerosisStatus unknownNCT02759211Not applicable
- Nightime NIV Initiation in Amyotrophic Lateral Sclerosis in an Outpatient SettingCompletedNCT02759003Not applicable
- Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple SclerosisCompletedNCT02753088Phase 3
- Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.CompletedNCT02750982Not applicable
- EPID Multiple Sclerosis Pregnancy StudyCompletedNCT02749396
- Repetitive Transcranial Magnetic Stimulation for Lower Limb Spasticity in Multiple Sclerosis PatientsSuspendedNCT02747914Not applicable
- RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.CompletedNCT02746744Phase 3
- Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple SclerosisCompletedNCT02744222Phase 2/3
- Online Program to Reduce Depression in MSCompletedNCT02740361Not applicable
- Depression and Immune Function in Multiple Sclerosis (MS)CompletedNCT02740296
- Effect of Active-Passive Trainer Cycling on Multiple SclerosisCompletedNCT02737904Not applicable
- Fatigue and Inspiratory Muscles Training in Patients With Multiple SclerosisTerminatedNCT02726672Not applicable
- Comparison of Intermittent vs. Continuous Walking in MSCompletedNCT02726373Not applicable
- Cognitive and Emotion Regulation Training in MSCompletedNCT02717429Not applicable
- Exercise in Multiple SclerosisTerminatedNCT02716701Not applicable
- Robot-based Rehabilitation of Upper Limb Impairment in Multiple SclerosisCompletedNCT02711566Not applicable
- Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02710162Early Phase 1
- Respiratory Strength Training in Persons With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02710110Early Phase 1
- High Intensity Interval Training for People With Mild Multiple Sclerosis: A Feasibility StudyCompletedNCT02702804Not applicable
- High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis PatientsCompletedNCT02696590Not applicable
- Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-studyCompletedNCT02695394
- Task-oriented Upper Limb Training in MSCompletedNCT02688231Not applicable
- TMP001 in Relapsing-remitting Multiple SclerosisCompletedNCT02686788Phase 2
- Tecfidera Diffusion Tensor ImagingCompletedNCT02686684
- Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALSCompletedNCT02686268
- Pharmacokinetics of DMF and the Effects of DMF on Exploratory BiomarkersCompletedNCT02683863Phase 4
- Teriflunomide Male Transmission StudyCompletedNCT02679885
- Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MSWithdrawnNCT02675413Phase 4
- Progressive Muscle Relaxation Effect on Sleep Quality, Depression and Stress in People With Multiple SclerosisCompletedNCT02673827Phase 2
- Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple SclerosisCompletedNCT02671682Not applicable
- Tongue Strength in Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT02665663Not applicable
- MSPT Device Usability StudyCompletedNCT02664324
- Aerobic Exercise and Brain Health in Multiple SclerosisCompletedNCT02661555Not applicable
- A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral SclerosisCompletedNCT02655614Phase 1
- Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)TerminatedNCT02654340
- Evaluation and Neural Basis of Communication in Patients With Multiple SclerosisCompletedNCT02652013Not applicable
- A Pilot Study of Intermittent Calorie Restriction in Multiple SclerosisCompletedNCT02647502Not applicable
- Tecfidera and MRI for Brain Energy in MSTerminatedNCT02644083
- Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm StudyStatus unknownNCT02644044Early Phase 1
- Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort StudyTerminatedNCT02642146
- This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Versus Placebo 1 Tablet PO QD in Subjects With Treatment-naïve RRMS for ≤ 3 YearsCompletedNCT02638038Phase 2
- Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory ArthritisCompletedNCT02636829Not applicable
- Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)CompletedNCT02635789Phase 3
- Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis ComplexCompletedNCT02634931Phase 3
- Attention/Working Memory Rehabilitation in Multiple Sclerosis: A Pilot Project Using Cogmed Working Memory TrainingCompletedNCT02634567Not applicable
- Observational Registry of Acthar Gel for Participants With Multiple Sclerosis RelapseCompletedNCT02633033
- Acute Effect of Fascial Mobilization on Gait in Patients With Multiple SclerosisStatus unknownNCT02628834Not applicable
- Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis PatientsCompletedNCT02623946
- A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical TrialCompletedNCT02618902Phase 1
- MRI Guided Focused Ultrasound for Tremor in Multiple SclerosisStatus unknownNCT02614989Not applicable
- An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple SclerosisCompletedNCT02612935
- Methodology Study of Novel Outcome Measures to Assess Progression of ALSCompletedNCT02611674
- Efficacy of MBI for Depressive Symptoms in Patients With MSCompletedNCT02611401Not applicable
- Self-Management Program Based on Physical Exercises in People With Multiple SclerosisStatus unknownNCT02607020Not applicable
- [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple SclerosisTerminatedNCT02606630Phase 1
- A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple SclerosisCompletedNCT02601885Phase 1
- Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis ConditionCompletedNCT02598167
- A RCT of Telephone-supported ACT in MSStatus unknownNCT02596633Phase 3
- Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic BurdenCompletedNCT02592265
- Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02590276Not applicable
- Food Supplement for the Treatment of Patients With Amyotrophic Lateral SclerosisWithdrawnNCT02588807Phase 1
- Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02588677Phase 2/3
- Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?CompletedNCT02588053
- A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMSStatus unknownNCT02587715Phase 1/2
- A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension PeriodCompletedNCT02587195Phase 3
- A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple SclerosisCompletedNCT02583594Phase 1
- Comprehensive Fall Prevention and Detection in Multiple SclerosisCompletedNCT02583386Not applicable
- In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02582385
- Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple SclerosisTerminatedNCT02580669Not applicable
- Deciphering the Role of the Gut Microbiota in Multiple SclerosisStatus unknownNCT02580435
- Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012CompletedNCT02579681Phase 3
- Hippocampal Sclerosis and Amnesia Not Due to Alzheimer's DiseaseCompletedNCT02576821Not applicable
- Answer ALS: Individualized Initiative for ALS DiscoveryCompletedNCT02574390
- Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS)CompletedNCT02572479
- Impacts of Different Training Modes (Intense Versus Ordinary) on the Immune System and Memory Functions in pwMSCompletedNCT02571335Not applicable
- Imaging and BioFluid Biomarkers in Amyotrophic Lateral SclerosisCompletedNCT02559869
- Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK.CompletedNCT02559765
- CSL Behring Sclero XIIIStatus unknownNCT02551042Phase 2
- Mitochondrial Dysfunction and Disease ProgressionCompletedNCT02549703
- Sport Therapy and Osteopathy Manipulative Treatment in ALSCompletedNCT02548663Not applicable
- Intrathecal Rituximab in Progressive Multiple SclerosisCompletedNCT02545959Phase 2
- Study of VSN16R for the Treatment of Spasticity in Multiple SclerosisCompletedNCT02542787Phase 2
- "New Perspectives of Adaptation to NIV in ALS"CompletedNCT02537132Not applicable
- Lakeshore Examination of Activity and Disability Exercise Response StudyCompletedNCT02533882Not applicable
- Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS)Status unknownNCT02529839Not applicable
- Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral SclerosisTerminatedNCT02528071
- Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive TherapyTerminatedNCT02525367Not applicable